Table 1 Clinical characteristics of the study group
From: Performance of brief ICF-sleep disorders and obesity core set in obstructive sleep apnea patients
Whole group (n/%) | No OSA (n/%) | OSA (n/%) | p value | |
|---|---|---|---|---|
Number | 592/100 | 162/100 | 430/100 | |
Men | 470/79.4 | 100/61.7 | 370/86.0 | < 0.0001 |
age | 49.21 ± 14.99 | 44.67 ± 16.43 | 50.93 ± 14.04 | 0.0233 |
BMI [kg/m2] | 27.25 ± 4.66 | 26.13 ± 4.42 | 27.58 ± 7.05 | 0.0016 |
Smoking | 263/44.4 | 46/28.4 | 217/50.5 | < 0.0001 |
Current smoker | 182/30.7 | 31/19.1 | 151/35.1 | 0.0001 |
Pack-years | 19.91 ± 19.85 | 20.97 ± 23.92 | 19.69 ± 19.00 | 0.7435 |
Quitting smoking | 93/15.7 | 15/9.3 | 78/18.1 | 0.0077 |
Quitting years | 7.807 ± 7.716 | 6.643 ± 8.854 | 8.033 ± 7.524 | 0.4775 |
NC | 39.47 ± 3.872 | 37.49 ± 3.79 | 39.99 ± 3.82 | < 0.0001 |
Diabetes mellitus | 87/14.7 | 17/10.5 | 70/16.3 | 0.0902 |
Arterial hypertension | 268/45.3 | 51/31.5 | 217/50.5 | < 0.0001 |
Short of breath | 162/27.4 | 37/22.8 | 125/29.1 | 0.1479 |
AHI | 21.00 ± 20.23 | 1.713 ± 1.522 | 26.08 ± 19.70 | < 0.0001 |
Max apnea time | 43.31 ± 28.11 | 15.43 ± 17.28 | 53.99 ± 23.81 | < 0.0001 |
SaO2 nadir | 79.72 ± 10.52 | 88.19 ± 5.64 | 76.47 ± 10.15 | < 0.0001 |
Max pulse | 109.7 ± 19.08 | 109.40 ± 20.47 | 109.8 ± 18.54 | 0.8531 |
4% decline of SaO2 index | 20.37 ± 19.06 | 5.04 ± 7.75 | 26.50 ± 18.79 | < 0.0001 |
rhinitis | 149/25.2 | 40/24.7 | 109/25.3 | 0.9157 |
pharyngitis | 127/21.5 | 24/14.8 | 103/24.0 | 0.0181 |
nasosinusitis | 16/2.7 | 5/3.1 | 11/2.6 | 0.7772 |
nasal polyp | 5/0.8 | 2/1.2 | 3/0.7 | 0.6180 |
polyp of vocal cord | 4/0.7 | 3/1.9 | 1/0.2 | 0.0645 |
polypectomy | 11/1.9 | 2/1.2 | 9/2.1 | 0.7356 |
Nasal septum deviation | 6/1.0 | 1/0.6 | 5/1.2 | 1.00 |